Gene variant found linking people of African descent to higher Parkinson’s risk
Dr. Ekemini Riley, managing director of ASAP, joins PBS NewsHour to discuss findings from the GBA1 discovery and the power of collaborative, open science to unlock discoveries for populations traditionally underrepresented in research.
UNILAG researchers unravel novel Parkinson’s genetic risk factor in Africans
The Guardian Nigeria reports on GP2 and its collaboration with the University of Lagos (UNILAG) to uncover a genetic variant that increases the risk of PD in Africans and African admixed populations.
A Parkinson’s ‘game changer,’ backed by Michael J. Fox, could lead to new diagnostics and, someday, treatments
STAT highlights how The Parkinson’s Progression Markers Initiative (PPMI) recently discovered how αSyn-SAA could be a novel tool for precision medicine approaches, earlier intervention, and improved clinical trial design for Parkinson's disease.
Exclusive: Google Cofounder Sergey Brin Has Quietly Donated More Than $1 Billion Toward Parkinson’s Disease
Forbes Magazine spotlights the ASAP initiative and the collective effort to accelerate the pace of discovery and inform the path to a cure for Parkinson's disease.
GP2 Cohort Dashboard Now Includes New Ancestry Categories
The updated GP2 Cohort dashboard now includes additional ancestry information across cohort samples that have already been processed and shared with the AMP® PD platform.
Congratulations to the 2022 COSA Prize Recipients
ASAP’s second annual Celebration of Scientific Achievement (COSA) showcased the outstanding contributions of young investigators across our Collaborative Research Network (CRN). This year’s event attracted over 400 participants, with 140 abstracts being showcased from across the network.
